Featured Product
This Week in Quality Digest Live
FDA Compliance Features
Jill Roberts
Another way to know what’s too old to eat
Patricia Santos-Serrao
Four pharma quality trends
Del Williams
Preventing damage caused by large, suspended particles
Kari Miller
An effective strategy requires recruiting qualified personnel familiar with the process and technology

More Features

FDA Compliance News
Now is not the time to skip critical factory audits and supply chain assessments
Google Docs collaboration, more efficient management of quality deviations
Delivers time, cost, and efficiency savings while streamlining compliance activity
First trial module of learning tool focuses on ISO 9001 and is available now
Free education source for global medical device community
Good quality is adding an average of 11 percent to organizations’ revenue growth
Further enhances change management capabilities
Creates adaptive system for managing product development and post-market quality for devices with software elements
VQIP allows for expedited review and importation for approved applicants that demonstrate safe supply chains

More News

Michael Causey

FDA Compliance

What the Heck’s Going On at the FDA?

FDA caught spying on its scientists

Published: Monday, July 23, 2012 - 13:07

The Cold War may be over, but apparently spying is still a growth industry. The latest spy-craft news comes from the seemingly staid Food and Drug Administration (FDA), which appears to have more George Smiley and John le Carré types than we’d ever imagined.

According to reports in The New York Times, The Washington Post, and others, the FDA has engaged in heavy-handed, systematic spying on its own scientists. This is not exactly the way to encourage the best and the brightest to do their best and brightest work.

The agency says it was only trying to make sure that information wasn’t improperly leaked. But at least one U.S. senator, Sen. Charles E. Grassley R-Iowa, isn’t buying that rationale at face value. As reported in the Post, Grassley wants to see the internal FDA memo authorizing the surveillance and who authorized it. Hearings aren’t unlikely, either. Watch for some FDA officials to get live grilling on C-Span during the coming months.

I’ve written about the tip of the iceberg earlier when it comes to politics and hiring at the FDA. You’ll recall its media office came under fire for allegedly forcing out some of the more experienced and, in some instances, conservative types in favor of a new and younger breed of folks who weren’t always demonstrably qualified for their positions.

Unfortunately, some with recent ties to the FDA say the place has become even more political than it was during the George W. Bush years, and that’s saying something.

Look, I love spy movies. Millions enjoy the novels of John le Carré and many other masters. Just last year, Tinker, Tailor, Soldier, Spy was a critically acclaimed film about spying at the highest levels in the British government.

The FDA’s spying games may not have quite the taut excitement of those thrillers, but they ought to scare us more. When the FDA even appears to be intimidating its scientists and other employees, it puts us all at risk.

We’ve already got a CIA in the alphabet soup of government; we don’t need the FDA to get into the act, too.

This article first appeared in the July 19, 2012, issue of the AssurX blog.


About The Author

Michael Causey’s picture

Michael Causey

James Michael Causey’s been a journalist since he started his own neighborhood newspaper in the 1970s. In addition to quizzing FDA officials for the past 10+ years, he’s also interviewed political satirist Art Buchwald, FCC Chairman Reed Hundt, SEC Chairwoman Mary Schapiro, and is the past president of the Washington Independent Writers. Causey is the editor and publisher of eDataIntegrityReport.com and is a contributing writer on the AssurXblog.